1. Home
  2. GLU vs RVPH Comparison

GLU vs RVPH Comparison

Compare GLU & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLU
  • RVPH
  • Stock Information
  • Founded
  • GLU 2004
  • RVPH 2006
  • Country
  • GLU United States
  • RVPH United States
  • Employees
  • GLU N/A
  • RVPH N/A
  • Industry
  • GLU Finance/Investors Services
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • GLU Finance
  • RVPH Health Care
  • Exchange
  • GLU Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • GLU 92.2M
  • RVPH 88.0M
  • IPO Year
  • GLU N/A
  • RVPH N/A
  • Fundamental
  • Price
  • GLU $15.51
  • RVPH $2.08
  • Analyst Decision
  • GLU
  • RVPH Strong Buy
  • Analyst Count
  • GLU 0
  • RVPH 5
  • Target Price
  • GLU N/A
  • RVPH $11.40
  • AVG Volume (30 Days)
  • GLU 12.4K
  • RVPH 1.8M
  • Earning Date
  • GLU 01-01-0001
  • RVPH 11-14-2024
  • Dividend Yield
  • GLU 8.60%
  • RVPH N/A
  • EPS Growth
  • GLU N/A
  • RVPH N/A
  • EPS
  • GLU 0.62
  • RVPH N/A
  • Revenue
  • GLU N/A
  • RVPH N/A
  • Revenue This Year
  • GLU N/A
  • RVPH N/A
  • Revenue Next Year
  • GLU N/A
  • RVPH N/A
  • P/E Ratio
  • GLU $22.50
  • RVPH N/A
  • Revenue Growth
  • GLU N/A
  • RVPH N/A
  • 52 Week Low
  • GLU $11.61
  • RVPH $0.60
  • 52 Week High
  • GLU $15.40
  • RVPH $4.83
  • Technical
  • Relative Strength Index (RSI)
  • GLU 57.11
  • RVPH 58.09
  • Support Level
  • GLU $15.40
  • RVPH $1.97
  • Resistance Level
  • GLU $15.68
  • RVPH $2.15
  • Average True Range (ATR)
  • GLU 0.31
  • RVPH 0.15
  • MACD
  • GLU 0.10
  • RVPH 0.02
  • Stochastic Oscillator
  • GLU 86.79
  • RVPH 78.74

About GLU Gabelli Global Utility of Beneficial Ownership

Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: